Journey Medical Corporation

US$4.47As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DERMHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (10.91%)
Div yield —
ROE (23.77%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.15
PE TTM —
TSR TTM (44.95%)
Mkt cap US$126.2M
ROIC (9.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.25
17.56%
29.06%
Hold 6|9|1|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.06
40.52%
20.00%
15.76%
19.21%
Revenue$M
11.21
11.76
12.33
12.94
3.73%
10.81%
10.17%
12.46%
Peers (US$126.2M)
Cap (US$)
PE
110.5M
—
126.0M
3.284x
Capital
TTM
5Y
10Y
Leveragex
2.805
(0.327)
(0.225)
EBIT/Intx
0.281
0.086
0.086
Own earn%
159.69
40.07
44.09
Sh yield%
37.96
12.63
11.70
Owners
Insiders/Inst%
13.73
54.97
Short interest%
4.54
SBC / revenue%
2.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
23–30
$1 testx
—
Incr. ROIC%
16